Skip to main content

Table 1 Demographic summary stratified by coronary artery disease status

From: Fully quantitative pixel-wise analysis of cardiovascular magnetic resonance perfusion improves discrimination of dark rim artifact from perfusion defects associated with epicardial coronary stenosis

 

NonCAD (N = 55)

CAD (N = 21)

p-value

Cardiovascular Risk Factors

 Age

53.0 ± 11.7

63.0 ± 10.1

0.001

 Male

29

53%

15

71%

0.195

 Hypertension

26

47%

14

67%

0.199

 Hyperlipidemia

26

47%

18

86%

0.004

 Diabetes

5

9%

5

24%

0.128

 Smoking

21

38%

12

57%

0.196

 Family history of CAD

14

25%

10

48%

0.097

 Body mass index (kg/m2)

29.1 ± 6.6

28.3 ± 4.6

0.81

Past Medical History

 Prior PCI

0

0%

3

14%

0.019

 CABGa

0

0%

0

0%

1.000

 Prior cerebrovascular accident

0

0%

1

5%

0.276

Medications

 Aspirin or Anti-Platelet

29

53%

15

71%

0.25

 Beta blocker

19

35%

11

52%

0.27

 Calcium channel blocker

4

7%

1

5%

0.84

 Nitrate

2

4%

1

5%

0.65

 Diuretic

8

15%

2

19%

0.94

 ACE inhibitor

13

24%

8

38%

0.35

 ARB

4

7%

2

10%

0.97

 Statin

22

40%

19

90%

< 0.001

  1. Abbreviations: ACE angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, BP blood pressure, CABG coronary artery bypass grafting, CAD coronary artery disease, LV left ventricular, LVEDV left ventricular end diastolic volume, LVESV left ventricular end systolic volume, LVEDMass left ventricular end diastolic mass, LGE late gadolinium enhancement, N/A not applicable, PCI percutaneous coronary intervention
  2. p values that were significant (p<0.050 or lower) are in bold
  3. aPatients with a prior history of coronary artery by-pass surgery and 3 vessel CAD were excluded from this study